Select Page
  1. Home »

Press Release

Sun Pharma receives DCGI approval for Molxvir® (Molnupiravir) in India
Read more

Press Release

Sun Pharmaceuticals announces approval of Winlevi® in Australia
Read More

The Sun Story

Watch the inspiring growth story of Sun – from humble beginnings in 1983 with just 2 employees and 5 psychiatry products to becoming the 4th largest global generic pharmaceutical company, selling over 2000 products in over 100 countries.

Subscribe on YouTube

SunPharma on Twitter

Sun Pharma Follow

Official account of world's 4th largest specialty generic pharmaceutical company. See our community guidelines: https://t.co/rYfTm9NUQQ

SunPharma_Live
sunpharma_live Sun Pharma @sunpharma_live ·
4 Jul

Sreenivas Rao, our Head of Global Supply Chain, shares how Sun's entrepreneurial spirit and strong customer focus have fuelled his dedication to the organization. Discover what drives his passion and commitment by watching his story here. #WeAreSun

Reply on Twitter 1808749208284926226 Retweet on Twitter 1808749208284926226 3 Like on Twitter 1808749208284926226 18 Twitter 1808749208284926226
sunpharma_live Sun Pharma @sunpharma_live ·
1 Jul

Watch Manisha Koirala’ story behind her second chance at life & why she is dedicating her #SecondBirthDate to her doctors on this #NationalDoctorsDay!

Reply on Twitter 1807664872324464825 Retweet on Twitter 1807664872324464825 808 Like on Twitter 1807664872324464825 751 Twitter 1807664872324464825
sunpharma_live Sun Pharma @sunpharma_live ·
30 Jun

This #NationalDoctorsDay, @thesushmitasen joins Sun Pharma in dedicating her #SecondBirthDate to the Doctors who gave her a second chance at life.

If you have a similar story, visit http://www.secondbirthdate.com to express gratitude to your doctor.

Reply on Twitter 1807438397473980587 Retweet on Twitter 1807438397473980587 870 Like on Twitter 1807438397473980587 890 Twitter 1807438397473980587
Retweet on Twitter Sun Pharma Retweeted
ipaofficialpage Indian Pharmaceutical Alliance @ipaofficialpage ·
27 Jun

Engaging panel at the 9th #GPQS2024 on 'Enhancing Current Cybersecurity: Securing the Digital Future' featuring Phani Mitra B (@drreddys), Sreeji Gopinathan (@LupinGlobal), Dheeraj Sinha (@SunPharma_Live), & Sanjay Moralwar (@ZydusUniverse).

Reply on Twitter 1806289783582228845 Retweet on Twitter 1806289783582228845 4 Like on Twitter 1806289783582228845 2 Twitter 1806289783582228845
sunpharma_live Sun Pharma @sunpharma_live ·
26 Jun

Proud moment for Sun! We've got not one but two feathers in our cap with @GPTW_India recognizing us as one of India's 50 Best Companies to Work For & Best Employers Among Nation-Builders 2024.
#bestemployersamoungnationbuilders #Indiasbestcompaniestoworkfor #GPTWCertified

Reply on Twitter 1805933949320892594 Retweet on Twitter 1805933949320892594 4 Like on Twitter 1805933949320892594 39 Twitter 1805933949320892594
sunpharma_live Sun Pharma @sunpharma_live ·
24 Jun

We are pleased to announce the successful completion of the merger of Taro with Sun Pharma.

Read more here: https://bit.ly/pressreleasetaromerger

Reply on Twitter 1805223557628313680 Retweet on Twitter 1805223557628313680 6 Like on Twitter 1805223557628313680 37 Twitter 1805223557628313680
sunpharma_live Sun Pharma @sunpharma_live ·
22 Jun

The results from a Phase I study evaluating the safety, tolerability, pharmacokinetics & pharmacodynamics of our GL0034 (Utreglutide) in obese adults, were presented at the 84th Scientific Sessions of the American Diabetes Association (ADA).
https://bit.ly/45FqtcO

Reply on Twitter 1804466036235731138 Retweet on Twitter 1804466036235731138 Like on Twitter 1804466036235731138 18 Twitter 1804466036235731138
sunpharma_live Sun Pharma @sunpharma_live ·
21 Jun

Sun Pharma has entered into a non-exclusive patent licensing agreement with Japanese pharmaceutical company, Takeda to introduce a novel Gastrointestinal Drug, Voltapraz (Vonoprazan) in India.

Read more here: https://bit.ly/3xoMY99

Reply on Twitter 1804127286381182987 Retweet on Twitter 1804127286381182987 Like on Twitter 1804127286381182987 17 Twitter 1804127286381182987
Load More

Find out more

Innovation

Science is at the heart of Sun Pharma. Our scientists work closely with doctors, patients, and business development teams, to generate innovative concepts and ideas to harness market needs and synergies across therapeutic areas.

Read more

Quality

Our vision is to globalize, harmonize and simplify GxP processes to achieve a sustainable quality culture.

Read more

Careers

We hire exceptionally talented individuals, and ensure they are nurtured professionally. Our multi-dimensional work environment offers high growth opportunities through challenging roles with clear responsibilities.

Read more

Responsibility

Our CSR efforts are focused on serving and helping needy and underprivileged communities. Our priority areas include: health, education, drinking water and sanitation.

Read more
Sun Pharma offers a program for individuals who want to disclose violations of US FDA requirements related to facilities or products owned or operated by Ranbaxy prior to Sun Pharma acquisition of Ranbaxy. Continue
Top